ICON

Dublin, Ireland Founded: 1990 • Age: 36 yrs
ICON plc is engaged in clinical research and drug development services.
Request Access

About ICON

ICON is a company based in Dublin (Ireland) founded in 1990. It operates as a Professional Services, and Managed Services. The company has 41,900 employees as of December 31, 2024. ICON has completed 18 acquisitions, including Aptiv Solutions, ClinicalRM and Firecrest Clinical. ICON offers products and services including Clinical Research Solutions, Consulting Services, and Technology Solutions. ICON operates in a competitive market with competitors including Medpace, Lambda Therapeutic, JCCT, Dhiti Life Sciences and Diacrin, among others.

  • Headquarter Dublin, Ireland
  • Employees 41900 as on 31 Dec, 2024
  • Stage Public
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Icon Plc
Operational Areas
Healthcare → Healthcare Services & Infrastructure
Key Metrics
  • Annual Revenue
    $8.28 B
    1.99
    as on Dec 31, 2024
  • Net Profit
    $791.47 M
    29.26
    as on Dec 31, 2024
  • EBITDA
    $1.73 B
    2.58
    as on Dec 31, 2024
  • Latest Funding Round
    $4.69 M (USD), Grant

    Sep 22, 2021

  • Investors
  • Employee Count
    41900

    as on Dec 31, 2024

  • Investments & Acquisitions
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

IPO & Listings of ICON

ICON is a publicly listed company on the NASDAQ with ticker symbol ICLR in USA, operating in the Commercial services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

Exchange: NASDAQ · Ticker: ICLR . Sector: Commercial services · USA

Products & Services of ICON

ICON offers a comprehensive portfolio of products and services, including Clinical Research Solutions, Consulting Services, and Technology Solutions. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Services for drug development are provided by ICON.

Strategic consulting for asset development is offered here.

Technology solutions for clinical research are developed comprehensively.

People of ICON
Headcount 10000+
Employee Profiles 1083
Employee Profiles
People
Dimitrios Sgourdos
Senior Information Technology Manager
People
Iwona M.
Global Clinical Manager
People
Sara Romeo
Senior Director, Business Development
People
Naice S.
Senior Site Manager (sr Cra)

Unlock access to complete

Funding Insights of ICON

  • Total Funding
  • Total Rounds 6
  • Last Round Grant — $4.7M
  • First Round

    (01 Sep 2015)

  • Investors Count 2
Date Amount Transaction Name Valuation Lead Investors Investors
Sep, 2021 Amount Grant - ICON Valuation

investors

Jul, 2018 Amount Grant - ICON Valuation

investors

Jan, 2018 Amount Grant - ICON Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in ICON

ICON has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Enterprise Ireland and European Union. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Institutional
Investor Description Founded Year Domain Location
Support is provided to Irish manufacturing and service sector businesses.
Founded Year Domain Location
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by ICON

ICON has strategically engaged in corporate development activities, having acquired 18 companies. Notable acquisitions include Aptiv Solutions, ClinicalRM and Firecrest Clinical. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Acquisitions
Company Name Description Domain Location Founded Year Amount
HumanFirst is integrated into ICON, focusing on digital health solutions.
2017
Provider of market access solutions for the biopharmaceutical and medical device industries
2015
Tax credits are identified, calculated, and processed for businesses.
2010
Company Name Description Domain Location Founded Year Amount
OVO is recognized as a smart digital payment application.
2017
Bionic investment advisor platform
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014

Financial Statements - ICON

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Icon Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of ICON

ICON operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Medpace, Lambda Therapeutic, JCCT, Dhiti Life Sciences and Diacrin, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
A range of clinical research services is offered by Medpace.
domain founded_year HQ Location
CRO with operations in India, US, Poland, Canada and UK. Winner of Frost & Sullivan 'CRO of the Year' - 2010
domain founded_year HQ Location
CRO focused on early & end stage clinical trial services
domain founded_year HQ Location
Biotechnology company offering in vitro diagnostic products for healthcare sector
domain founded_year HQ Location
Educational programs are provided by Diacrin since 1989.
domain founded_year HQ Location
Performs clinical research trials to evaluate investigational drugs and devices.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Icon

Frequently Asked Questions about ICON

When was ICON founded?

ICON was founded in 1990 and raised its 1st funding round 25 years after it was founded.

Where is ICON located?

ICON is headquartered in Dublin, Ireland.

How many employees does ICON have?

As of Dec 31, 2024, the latest employee count at ICON is 41,900.

What is the annual revenue of ICON?

Annual revenue of ICON is $8.28B as on Dec 31, 2024.

What does ICON do?

ICON plc is recognized as a leading Contract Research Organization (CRO) focused on clinical research and drug development. Services are provided across various sectors including biotechnology, pharmaceuticals, medical devices, and public health. Comprehensive solutions are offered, ranging from early-phase trials to post-marketing support. Specialized therapeutic expertise is delivered in areas such as oncology, cardiovascular, and rare diseases. Innovative technologies and patient-centric approaches are integrated to enhance trial efficiency. Strategic consulting and real-world intelligence are also provided to optimize RD outcomes for clients globally.

Who are the top competitors of ICON?

ICON's top competitors include Medpace, Lambda Therapeutic and Dhiti Life Sciences.

What products or services does ICON offer?

ICON offers Clinical Research Solutions, Consulting Services, and Technology Solutions.

Is ICON publicly traded?

Yes, ICON is publicly traded on NASDAQ under the ticker symbol ICLR.

How many acquisitions has ICON made?

ICON has made 18 acquisitions, including Aptiv Solutions, ClinicalRM, and Firecrest Clinical.

Who are ICON's investors?

ICON has 2 investors. Key investors include Enterprise Ireland, and European Union.

What is ICON's ticker symbol?

The ticker symbol of ICON is ICLR on NASDAQ.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available